Chronic Disease Management Market to See 7.2% Annual Growth Through 2024
BCC Research Finds That Chronic Disease Management Grows due to Prevalence and Awareness of Chronic Illness
December 18, 2019
WELLESLEY, Mass., Dec. 18, 2019– The chronic disease market is fuelled by a superior clinical results of new drugs and biologics, increasing trend of digital health and the U.S. Patient Protection and Affordable Care Act, according to a report by BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets.”
The market for chronic disease management expects to see a compound annual growth rate (CAGR) of 7.2% through 2024, when it could be worth $490 billion.
Major players in the market include: Agenus (AGEN), Apotex and Philosys.
Research Highlights
- The US region is projected to reach $248 billion, increasing at a CAGR of 8% by 2024.
- Europe is the second-largest market, and is expected to reach $143 billion by 2024, growing at a CAGR of 6.4%.
- The Asian market of chronic disease management therapeutics and device technologies is expected to witness the highest growth through 2024.
Read the full report here: https://www.bccresearch.com/market-research/healthcare/chronic-disease-management-market-report.html
“Chronic diseases are complex in nature and need long-term treatment and care in hospitals and within home care, according to BCC Research analyst Dr. Ritu Thakur. “Home care accounts for the largest share of the chronic disease therapeutics and device technologies market, followed by hospitals and other settings.”
Therapeutics to See Continued Growth Due to Innovative Drugs and Wearable Devices
Therapeutics has witnessed significant progress in the past two decades, and the trend is expected to continue with new and innovative drugs and biologics targeting unmet needs. With recent technological advances, advanced wearable device technologies and improved treatment adherence solutions are beginning to enter the mainstream management solutions for chronic diseases, in addition to therapeutics.
Editors/reporters requesting analyst interviews should contact Sarah Greenberg at press@bccresearch.com.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets( HLC239A )
Publish Date: Nov 2019
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Market for Emerging Medical Device Technologies to Hit $223.9 Billion by 2029
- Emerging Clinical Trial Infrastructure in the MENA Region: A Comprehensive Market Analysis
- IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market
- Global Colorectal Cancer Screening and Diagnostics Market to Reach $46.1 Billion by 2029
- Global Medical Imaging Market Projected to Reach $82.6 Billion by 2029, According to BCC Research
Reports from Health Maintenance
Recent News
- BCC Research Presents 2024 Diagnostics Research Review: Market Growth and Innovations
- CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years
- BCC Research Releases 2024 Protein Synthesis Research Review
- Global Industrial Enzyme Markets: Innovation, Impact, and Growth
- DNA and RNA Sequencing Markets Set for Rapid Expansion, Says BCC Research